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Objective: Collagen type 2 (Col2)-Cre or tamoxifen-inducible Col2-CreER transgenic mouse lines have
been used for studies to explore the cellular and molecular pathogenesis of osteoarthritis (OA). The
purpose of this study is to investigate whether the targeted cells are the same or different in the two
mouse lines.
Methods: We crossed tamoxifen inducible Col2-CreER and Col2-Cre mice with Rosa tdTomato reporter
mice and analyzed the labeling patterns at different time points.
Results: In the Col2-CreER mice, 90.8 [95% conﬁdence interval (CI) (88.3, 93.2)] and 82.8 (77.4, 88.3) % of
the articular surface cells are Tomato positive when tamoxifen was administered at 2 and 2.5 weeks of
age and strong activity was observed even 4.5 months after injection. However, 46.0 (32.8, 59.1) and 22.2
(11.7, 32.6) % of the surface cells were Tomato positive when tamoxifen was administered at 3 and 4
weeks of age, respectively. Little to no Tomato activity in the articular surface cells was observed when
tamoxifen was administered at 8 weeks of age. At any stage of tamoxifen injection, the Tomato activity
was detected in growth plate and epiphyseal bone in addition to articular chondrocytes, but little in
endosteum and not in the synovium and ligament. In contrast, the targeted tissues in the Col2-Cremouse
line were articular cartilage, growth plate, meniscus, endosteum, ligament, bone and synovium.
Conclusions: This study demonstrates that the pattern of targeted cells in the inducible Col2-CreER mice
are partially overlapping with but different from that of targeted cells in Col2-Cre mice and the pattern
varies dependent on when tamoxifen is administered.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a degenerative joint disease causing
dysfunction of articular cartilage. Genetic association studies sug-
gest that genetic factors contribute signiﬁcantly to the pathogen-
esis of OA. However, the roles of such factors in the cellular and
molecular mechanisms of OA pathogenesis are largely unknown.
Collagen type II is an early marker of chondrogenesis.While it is a
major product of chondrocytes, it is also synthesized by other cell
types. In synovial joint regions of adult mice, the expression of the
Col2a1 (Col2) gene is detected in growth plates, meniscus, articular
cartilage and subchondral bone. Cells expressing cre-recombinase
driven by the Col2 promoter include both chondrocytes and non-: B.R. Olsen, 188 Longwood
.
o: M. Nagao, 188 Longwood
.
du (M. Nagao), bjorn_olsen@
ternational. Published by Elsevier Lchondrocytes1,2. Recent lineage mapping studies showed that the
promoter is induced in perichondrial osteoblastic precursors and
bone marrow stromal/mesenchymal stem cells in addition to chon-
drocytes. Inaddition, the skeletal tissues thatare targeted inmicewith
tamoxifen-inducible Col2-Cre (Col2-CreER) have been shown to vary
dependent on the developmental stage when tamoxifen is adminis-
trated3.Col2-Creor tamoxifen-inducibleCol2-CreER transgenicmouse
lines havebeenused forOA studies, butwhether the targeted cells are
the same or different in the two mouse lines have not been investi-
gated. In this study,weperformed a lineagemapping studywithCol2-
Cre and Col2-CreER mice crossed with Rosa tdTomato reporter mice
and analyzed the labeling patterns at different time points.Materials and methods
Mice
Col2-Cre4 mouse line has been described previously. Col2-Cre
ERT mice5 and B6. Cg-Gt(Rosa)26Stortm14(CAG-tdTomato)Hze/Jtd. All rights reserved.
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Laboratories. The Cre recombination efﬁciency was evaluated by
Tomato ﬂuorescence in the Col2-Cre or Col2-creERmice mated with
the tdTomatomice. Miceweremaintained at speciﬁc-pathogen-free
conditions and housed in group of 3e5mice per cage. Mice had free
access to irradiated feed (Purina 5058, PicoLab Mouse Chow) and
water. Genomic DNA isolated from portions of mouse tails were
used for genotyping. The sequence of PCR primers for Cre were:
forward 50-GAACCTGATGGACATGTTCAGGGA-30; reverse 50 eCAGA
GTCATCCTTAGCGCCGTAAA-30. The sequence of PCR primers for
tdTomatowere: forward 50. All animal experiments were performed
according to protocols approved by the Harvard Medical Area
Standing Committee on Animals in accordance with US Public
Service Policy on Humane Care and Use of Laboratory Animals.Tamoxifen injection
Tamoxifen (T5684, SigmaeAldrich) was dissolved in corn oil at a
concentration of 20 mg/ml by shaking overnight at 37C. Animals
received 75 mg tamoxifen/kg body weight intraperitoneally onceFig. 1. Labeling pattern of the Col2-CreERmice. Histology sections from the knee joint from
with tamoxifen (75 mg/kg bodyweight/day for 5days) or corn oil. Tamoxifen was administra
control (h). Histology sections from the knee joint from 20 weeks old Col2-CreERT;tdTomatom
of age (j). Tamoxifen was administrated at 8 weeks of age (ken) and analyzed 1 week (k)
represents Tomato and blue represents DAPI. s, synovium; m, meniscus; a, anterior cruciatdaily for a total of 5 consecutive days. Tamoxifen-oil mixture was
stored at 20C until used.Histology
Mice limbs were dissected, soft tissues were removed and ﬁxed
in 4% paraformaldehyde for 48 h at 4C and then decalciﬁed in
0.5M EDTA (PH 8.0) at 4C on a shaker for periods ranging from 7 to
14 days. Complete decalciﬁcation was conﬁrmed by digital radi-
ography (In Vivo MS FX PRO, Bruker Co). The tissues were cry-
oprotected in 15% sucrose/PBS for 1hr and 30% overnight at 4C and
then placed in 30% sucrose/PBS:OCT (1:1) solution for 1hr. Samples
were embedded in Tissue-Tek O.C.T. compound (Sakura, 4583) and
transferred to dry ice to solidify the compound. Embedded samples
were cryosectioned at 10 mm using a cryostat (OTF 5000, Bright
Instrument Co Ltd.). Images were taken with Nikon 80i Upright
microscope (Nikon Co.). Images of some optic ﬁelds were taken
using blue and red ﬂuorescence ﬁlters, and merged with Meta-
Morph Software (Molecular Devices LLC.).9 weeks old Col2-CreERT;tdTomato male mice (n ¼ 4) (aeg) injected intraperitoneally
ted at 2 weeks (aed), 2.5 weeks (e), 3 weeks (f) and 4 weeks of age (g). No-Tamoxifen
ale mice (n ¼ 4) injected intraperitoneally with tamoxifen at 2 weeks (i) and 2.5 weeks
, 2 weeks (l), 3 weeks (m) or 4 weeks (n) after the ﬁrst day of injection (n ¼ 3). Red
e ligament. Scale bar, 100um.
Fig. 2. Labeling pattern of the Col2-Cre mice. Histology sections from the knee joint from 9 weeks old male mice (n ¼ 4). Tomato activity in the Col2-Cre;tdTomato mice (aeg). Cre
negative control (h). Red represents Tomato and blue represents DAPI. s, synovium; m, meniscus; gp, growth plate; a, anterior cruciate ligament. Scale bar, 100um.
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Tomato positive cells 20um away from the articular surface in
tibia and femur of the Col2-CreER male mice were counted and
were divided by the number of DAPI positive articular surface cells.
Male mice were used for each experiment and statistical compar-
isons were analyzed by one-way ANOVA with a Bonferroni's mul-
tiple comparison. P values < 0.05 were considered statistically
signiﬁcant. All analyses were performed using the GraphPad Prism
6 (GraphPad Software, Inc. CA) software.Results
To explore patterns of targeted cells in the Col2-CreER mice
when tamoxifen was administered at earlier stages, we injected
tamoxifen intraperitoneally for 5 consecutive days from the ﬁrst
day of injection at ages of 2, 2.5, 3 and 4 weeks and sections were
analyzed at 9 weeks of age. As shown in the Figures, Tomato activity
was detected in articular chondrocytes, growth plate and epiphy-
seal bone [Fig. 1(a) and (b)], but no activity was observed in the
synovium [Fig. 1(c)] and ligament [Fig. 1(d)], when tamoxifen was
administered at 2 weeks of age. In the case of articular chon-
drocytes, Tomato activity was dependent on the age at which
tamoxifen was administered. 90.8 [95% conﬁdence interval (CI)
(88.3, 93.2)] % of articular chondrocytes were Tomato positivewhen
tamoxifen was injected at 2 weeks and 82.8 (77.4, 88.3) % when
tamoxifen was injected at 2.5 weeks [Fig. 1(b) and (e)]. In contrast,
46.0 (32.8, 59.1) % and 22.2 (11.7, 32.6) % of articular chondrocytes
were positive when tamoxifenwas injected at 3 and 4 weeks of age,
respectively, in the Col2-CreER mouse line [Fig. 1(f) and (g)]. Sta-
tistical analysis showed that Tomato positive cells when tamoxifen
was injected at 3 or 4 weeks of age are signiﬁcantly less labeled
compared to the cells when tamoxifen was injected at 2 weeks of
age (P < 0.0001 and P < 0.0001, respectively). A low level of
tamoxifen-independent Tomato activity was detected in articular
cartilage and subchondral bone [Fig. 1(h)]. 86.4 (80.3, 92.5) % and
80.8 (78.6, 83.1) % of articular chondrocytes were still positive even
after more than 4 months after tamoxifen was injected, whentamoxifen was injected at 2 or 2.5 weeks of age, respectively
[Fig. 1(i) and (j)].
To identify which types of cells were targeted in Col2-CreERmice
when tamoxifen was injected at a later stage, tamoxifen was
administrated at 8 weeks of age and tissues were analyzed 1, 2, 3
and 4 weeks after the ﬁrst day of injection. As shown in the ﬁgure,
abundant Tomato activity was detected in growth plate chon-
drocytes and epiphyseal bone even 1 week after the ﬁrst day of
injection [Fig. 1(k)] and the activity was similar at every stage
[Fig. 1(l)e(n)]. However, little to no Tomato activity was detected in
the articular cartilage, meniscus and synovium in the Col2-CreER
mice [Fig. 1(k)e(n)].
To identify the targeted cells in the Col2-Cre mouse line, we
generated Col2-Cre;tdTomato transgenic mice and Tomato activity
was examined in the knee joint at 8 weeks of age. As shown in
Fig. 2, the targeted tissues were articular cartilage [Fig. 2(a) and (b)],
meniscus [Fig. 2(a)e(d)], growth plate [Fig. 2(a) and (e)], endos-
teum [Fig. 2(a)e(e)], bone [Fig. 2(a)e(g)], ligaments [Fig. 2(f) and
(g)] and synovium [Fig. 2(c) and (d)]. The 8 weeks old Col2-Cre
mice showed that almost all cells in articular cartilage were tar-
geted [Fig. 2(a) and (b)]. In contrast to the inducible Col2-CreER
mouse with tamoxifen injection, no Tomato activity was detected
in the knee joint of Cre-negative control mice [Fig. 2(h)].Discussion
In this study, we demonstrate that the patterns of targeted cells
in inducible Col2-CreER mice when tamoxifen is administered
postnatally are partially overlapping with but different from the
targeted cells in Col2-Cre mice. We also demonstrate that the pat-
terns of targeted cells in the inducible Col2-CreERmouse depend on
when tamoxifen is administered.
Previous studies using the Col2 promoter showed that many
types of molecules contribute to the progression of articular joint
disease in OA6. While some studies analyzed mRNA expression
levels, protein levels or used reporter mice to conﬁrm that articular
cartilage was efﬁciently targeted, the effects on other types of tis-
sues such as synovium, ligament, meniscus and subchondral bone
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Cre nor tamoxifen-inducible Col2-CreER mice target chondrocytes
in a speciﬁc manner but that several kinds of mesenchymal lineage
cells are targeted is consistent with previous studies in which
embryonic activation of Col2-Cre promoter labels bone pro-
genitors3,7. The effects on several types of cells in addition to
articular chondrocytes need to be considered in experimental
studies using Col2 promoter-based methods to study synovial joint
alterations.
The inducible Col2-CreER mice that were used in this study
represents a good model for targeting speciﬁc genes in articular
chondrocytes and avoid effects in the synovium and ligament,
when tamoxifen is administered at 2 weeks after birth. The tar-
geting effect lasts at least 4.5 months. However, articular chon-
drocytes are insufﬁciently targeted when tamoxifen is injected at 3
weeks of age or later. It also would be important that Col2
expression in OA is reported to be altered8, while our study showed
that the expression in normal articular chondrocytes is age
dependently decreased.
This study has a limitation that we did not compare male and
female mice. Although our pilot study showed that initial Tomato
activity was not different (data not shown), it is possible that tar-
geting cells after tamoxifen administration in Col2-CreER mice is
not the same in the two genders.
In previous OA studies, 3 different tamoxifen-inducible Col2-
CreER mouse lines have been used4,5,9,10. In these studies, tamox-
ifen was administered at various time points, ranging from 2 to 8
weeks after birth to evaluate genetic effects in the development of
OA11e13. Although these Col2 transgenic lines are almost identical,
the speciﬁcity and efﬁciency of Cre activity may differ. Taking into
account the speciﬁc mouse line used and the timing of tamoxifen
administration is clearly important when interpreting the data.
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